Previous 10 | Next 10 |
10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023 PR Newswire PLEASANTON, Calif. , Oct. 11, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it will report f...
10x Genomics Comments on Second UPC Preliminary Injunction Decision PR Newswire UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString's CosMx Products in Europe Remain in Full Effect PLEASANTON, Calif. , Oct. 10, 2023 /PRN...
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe PR Newswire Second Injunction Issued Against CosMx PLEASANTON, Calif. , Sept. 19, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader ...
2023-09-19 10:11:41 ET More on NanoString, 10x Genomics Seeking Alpha’s Quant Rating on NanoString 10x Genomics: Recent Performance Amplifies My Bullish Conviction NanoString gains amid new counterclaims in patent dispute with 10x Genomics NanoString T...
10x Genomics Expands Gene Expression Flex Offering with New High-Throughput Multiomic Profiling Kit PR Newswire Strengthen cellular analysis with cost-efficient multiomic readouts and streamlined workflows PLEASANTON, Calif. , Sept. 14, 2023 /PRNewswire/ ...
2023-09-08 10:46:39 ET Summary 10x Genomics reported impressive Q2 performance with revenue growing by 28% YoY to reach $147M. The company's growth is driven by strong performance in both single-cell and spatial biology portfolios. Despite challenges in the Chinese market and ...
TORONTO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) is pleased to report initial results from the 2023 drilling program at EPO, a deposit located to the north of the Media Luna deposit, in close proximity to the G...
Study Enabled by 10x Genomics Single Cell and Spatial Technologies Explains Why Immunotherapy is More Effective for Certain Brain Tumors Than Others PR Newswire Researchers uncover mechanisms behind divergent responses to immune checkpoint blockade between primary and metastat...
10x Genomics to Present at the Morgan Stanley 21st Annual Global Healthcare Conference PR Newswire PLEASANTON, Calif. , Aug. 30, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of it...
10x Genomics Surpasses 100 Xenium Analyzer Shipments PR Newswire Rapid growth and adoption of Xenium Analyzer demonstrates strength of company's innovation engine, broad commercial reach and operational scale PLEASANTON, Calif. , Aug. 29, 2023 /PRNewswire...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:09 ET Kyle Mikson from Canaccord Genuity issued a price target of $32.00 for TXG on 2024-07-23 05:09:00. The adjusted price target was set to $32.00. At the time of the announcement, TXG was trading at $18.11. The overall price target consensus is at $24...
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...